Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical research community for over a year fighting the perception that its drug-coated stents may…
The National Funeral Directors Association must be sending “thank you” cards to Eli Lilly (LLY) and it partner Amylin (AMLN). Together, the companies developed and market diabetes drug Byetta. The firms had told the…
Biodel Inc. (NASDAQ: BIOD) has filed with the SEC to sell up to 8.5 million shares of common stock. The company will sell 5.5 million of the shares and 3 million of the shares…
Alpharma, Inc. (NYSE: ALO) has already responded to King Pharmaceuticals Inc. (NYSE: KG) regarding the $33.00 per share offer made by King to acquire Alpharma. As we noted based upon the premium trading to…
If there wasn’t enough already wrong with the FDA drug approval process, diabetes drug Byetta, created for patients by Elli Lilly (LLY) and Amylin Pharmaceuticals (AMLN) is killing more people. The news follows an…
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.
Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will result in net proceeds of roughly $297.9 million. The sole manager of the offering…
We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides of the stock. The company has just announced that management will not be presenting…
Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY) regarding the cash buyout of the company. The company’s board of directors has formed…
CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold 5 million shares at a price of $26.50 per share. All shares were being…
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We do not want to try to sound as though this TYSABRI news is something…
Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a buyout offer from Bristol-Myers (NYSE: BMY) at $60.00 per share. As per the filing:…
Align Technology Inc. (NASDAQ: ALGN) has just posted some mixed earnings. Regardless of Wall Street’s and Main Street’s love of Invisalign, the stock is being pounded. The company reported earnings at $0.06 EPS on…
Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis news would render this particular earnings report immaterial. The biotech giant just posted adjusted…
After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s strong osteoporosis data has suddenly gotten the company out of the gutter and suddenly…